A carregar...
Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells
Imatinib, a multitargeted receptor tyrosine kinase inhibitor, is used as the standard initial therapy against inoperable gastrointestinal stromal tumor (GIST). However, GIST can acquire resistance to imatinib within several years of therapy. The development of oncolytic reovirus as an anticancer age...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777799/ https://ncbi.nlm.nih.gov/pubmed/29383187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23361 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|